GLDN Antikörper (N-Term)
Kurzübersicht für GLDN Antikörper (N-Term) (ABIN6751437)
Target
Alle GLDN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human GLDN / Gliomedin
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human GLDN (Q6ZMI3-2). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey, Galago, Elephant, Bovine, Bat, Rabbit, Pig, Guinea pig, Zebrafish (100%), Marmoset, Panda, Dog, Horse (92%), Mouse, Opossum (91%), Lizard, Xenopus, Stickleback, Sea anemone (84%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- GLDN (Gliomedin (GLDN))
-
Andere Bezeichnung
- GLDN / Gliomedin
-
Hintergrund
-
Name/Gene ID: GLDN
Synonyms: GLDN, Colmedin, CRG-L2, CLOM, COLM, CRGL2, Gliomedin, UNC-112, Collomin -
Gen-ID
- 342035
-
UniProt
- Q6ZMI3
Target
-